Changeflow GovPing Healthcare & Life Sciences Rabbit Antigen Binding Protein Nucleic Acid Lib...
Routine Notice Added Final

Rabbit Antigen Binding Protein Nucleic Acid Libraries and Methods

Favicon for changeflow.com USPTO Patent Applications - Biotech (C12N)
Published
Detected
Email

Summary

USPTO published patent application US20260110113A1 for rabbit-derived antigen binding protein nucleic acid libraries that specifically recognize target peptide-MHC (pMHC) complexes. Inventors include Anna Maria Sobieraj, Severin Oliver Wendelspiess, and Fabian Bert Scheifele. The application was filed September 5, 2025, with CPC classifications covering C40B, C12N, and C07K technology areas.

“Rabbit antigen binding protein nucleic acid libraries are provided (e.g., nucleic acid libraries encoding antigen binding proteins that specifically recognize a target peptide-MHC (pMHC)).”

USPTO , verbatim from source
Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Applications - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 263 changes logged to date.

What changed

USPTO published patent application US20260110113A1 for rabbit-derived antigen binding protein nucleic acid libraries and methods of producing them. The application covers nucleic acid libraries encoding antigen binding proteins that specifically recognize target peptide-MHC (pMHC). Inventors: Anna Maria Sobieraj, Severin Oliver Wendelspiess, and Fabian Bert Scheifele. The application was filed September 5, 2025.\n\nAffected parties in biotechnology and pharmaceutical research should review for potential licensing or freedom-to-operate implications. The patent application may affect IP strategy for companies developing pMHC-targeted therapeutics or diagnostics.

Archived snapshot

Apr 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

RABBIT-DERIVED ANTIGEN BINDING PROTEIN NUCLEIC ACID LIBRARIES AND METHODS OF MAKING THE SAME

Application US20260110113A1 Kind: A1 Apr 23, 2026

Inventors

Anna Maria Sobieraj, Severin Oliver Wendelspiess, Fabian Bert Scheifele

Abstract

Rabbit antigen binding protein nucleic acid libraries are provided (e.g., nucleic acid libraries encoding antigen binding proteins that specifically recognize a target peptide-MHC (pMHC)). Methods of producing the rabbit antigen binding protein nucleic acid libraries are also provided.

CPC Classifications

C40B 30/04 C12N 15/1086 C07K 2317/31 C07K 2317/55 C07K 2317/565

Filing Date

2025-09-05

Application No.

19320145

View original document →

Get daily alerts for USPTO Patent Applications - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 23rd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260110113A1

Who this affects

Applies to
Pharmaceutical companies
Industry sector
3254.1 Biotechnology
Activity scope
Patent application Biotech research
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!